Hanmi Pharm. Co.
128940.KO
201.02 USD
-0.34
-0.17%
h
Overview
Last close
201.02 usd
Market cap
2.55B usd
52 week high
279.68 usd
52 week low
193.82 usd
Target price
286.21 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.2713
Price/Book Value
3.3016
Enterprise Value
2.74B usd
EV/Revenue
2.4486
EV/EBITDA
5.5134
Key financials
Revenue TTM
1.12B usd
Gross Profit TTM
514.02M usd
EBITDA TTM
260.56M usd
Earnings per Share
N/A usd
Dividend
0.54 usd
Total assets
1,975.73B usd
Net debt
N/A usd
About
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.
- Symbol128940.KO
- ExchangeKO
- IsinKR7128940004
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Jae-Hyun Park
- HeadquarterHwaseong-si
- Web sitehttps://www.hanmipharm.com
